首页 › 胶质母细胞瘤 › 纽约州

纽约州的胶质母细胞瘤临床试验

纽约州有 33 项针对胶质母细胞瘤的研究正在招募参与者。

纽约州的城市

官方研究文本（英文）

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Weill Cornell Medicine, New York
NewYork-Presbyterian / Columbia University Irving Medical Center, New York
Lennox Hill Hospital, New York

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT05902169

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Westchester Medical Center, Valhalla

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月5日 · NCT07195591

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

New York University Langone's Perlmutter Cancer Institute, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT06991101

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center*, New York

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT03970447

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
Columbia University Irving Medical Center, New York
Montefiore Medical Center, The Bronx

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07326566

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

Lenox Hill Hospital, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT05303467

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

New York University Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT05765812

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Memorial Sloan Kettering Cancer Center, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月18日 · NCT07089641

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Montefiore Medical Center-Einstein Campus, The Bronx
Montefiore Medical Center-Weiler Hospital, The Bronx
以及另外 1 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月10日 · NCT07452458

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Icahn School of Medicine at Mount Sinai - Oncology, New York
Memorial Sloan Kettering Cancer Center New York - Main Campus, New York

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月10日 · NCT06914128

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
以及另外 1 项

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT06934889

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年9月2日 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

NYU Langone Health, New York
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
以及另外 2 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年8月28日 · NCT05303519

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

Memorial Sloan Kettering Cancer Center, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年8月19日 · NCT02977780

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

NYU Langone Health, New York

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年7月30日 · NCT07464925

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

NYU Langone Health, New York

招募中

18 至 85 岁 · 所有性别 · 更新于 2026年7月21日 · NCT06910306

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

Albany Medical Center, Albany
Dent Neurologic Institute, Buffalo
Northwell Health, Long Island City
以及另外 4 项

招募中2 期

18 至 80 岁 · 所有性别 · 更新于 2026年7月17日 · NCT07225621

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Lenox Hill Hospital, New York

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年7月1日 · NCT06805305

A Study of 177Lu-PSMA-617 in People With Gliomas

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
以及另外 1 项

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年6月4日 · NCT07223034